<DOC>
	<DOCNO>NCT00488436</DOCNO>
	<brief_summary>The different mechanism action Antithymocyte globulin cyclosporine improve effectivity use combination patient myelodysplastic syndrome .</brief_summary>
	<brief_title>Antithymocyte Globulin Cyclosporine Treating Low Risk Patients With Myelodysplastic Syndrome</brief_title>
	<detailed_description>Patients treat : Antithymocyte globulin ( Timoglobulin SangStat ) - 2,5 mg/kg/day IV 8 hour day 1-4 - Total dose : 10 mg/kg - Calculated dose adjust ideal weight - Especial consideration : Paracetamol 1 gr ( oral IV ) Dexclorfeniramine 5 mg IV Methylprednisolone 1 mg/kg IV 30 minute Timoglobulin repeat necessary 4 hour - Platelet transfusion platelet count &lt; 50 x 109/L Cyclosporine ( Sandimmun Neoral ) -2,5 mg/kg/12 h 3 month</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Myelodysplastic Syndromes</mesh_term>
	<mesh_term>Preleukemia</mesh_term>
	<mesh_term>Antilymphocyte Serum</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<criteria>Diagnosis low intermediate risk myelodysplastic syndrome ( MDS ) ( high risk patient eligible intensive chemotherapy bone marrow transplantation ) , exclude chronic myelomonocytic leukemia At less one two follow condition : Transfusion dependence : 1 ) Packed red blood cell transfusion great 2 time ; 2 ) Untransfused hemoglobin level great 10 g/dL ; 3 ) Platelet transfusion great 1 time Infection grade III IV secondary neutropenia ECOG &lt; = 2 Chronic myelomonocytic leukemia Creatinine great 2 mg/dl Bilirubin great 2.5 mg/dl History heart failure History allergy rabbit protein</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2008</verification_date>
	<keyword>Myelodysplastic Syndrome</keyword>
	<keyword>Antithymocyte Globulin</keyword>
	<keyword>Cyclosporine</keyword>
</DOC>